Ropes & Gray advised ImmunoGen, while Walder Wyss advised the funds managed by Pharmakon Advisors. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into a term loan...
ImmunoGen’s $175 Million Term Loan Financing
Silversmith Capital Partners and Health Velocity Capital’s Investment in Fortified Health Security
Ropes & Gray represented a consortium led by Silversmith Capital Partners and Health Velocity Capital on the deal. A consortium led by Silversmith Capital Partners and...
National Resilience’s $110 Million Alliance with Bluebird Bio to Develop Cell Therapies
Ropes & Gray advised National Resilience on the deal. National Resilience, Inc., a biopharmaceutical manufacturing specialist, closed a strategic alliance with bluebird bio, Inc., to accelerate...